Author: mrr5831
-
New DNA Identification Approach Could Improve Monitoring for Chronic Diseases
Investigators led by Shana Kelley, PhD, have developed a novel approach for identifying sequences of artificial DNA with differing levels of binding to other small molecules, which could improve diagnostic monitoring for patients with chronic diseases.
-
New Therapeutic Target for Parkinson’s Disease Discovered
Northwestern Medicine scientists have uncovered a new mechanism by which mutations in a specific gene contribute to familial forms of Parkinson’s disease, which opens an avenue for new therapeutics.
-
Metformin May Prevent Long COVID, Trial Finds
Metformin, a drug commonly used to treat diabetes, may prevent the development of “long COVID,” according to a clinical trial published in The Lancet Infectious Diseases.
-
Immunotherapy Improves Remission for Relapsed, Refractory Leukemia
A single infusion of CAR T-cell therapy induced complete response or remission in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma, according to a recent clinical trial published in The Lancet.
-
More Green Spaces Linked to Slower Biological Aging
Living near to green spaces were associated with slower biological aging, according to a Northwestern Medicine study published in Science Advances.
-
PA Student Competes in Olympic Trials for Race Walking
Anali Cisneros, a first-year student in Feinberg’s Physician Assistant (PA) Program, is an Olympic-level athlete in race walking and recently competed at the Olympic trials for the Tokyo Summer Olympic games.
-
Study Identifies Mechanisms Driving Immune Cell Recruitment During Inflammation
Northwestern Medicine investigators have discovered a novel mechanism that regulates neutrophil recruitment into tissue during inflammation, which could be targeted to treat different inflammatory diseases and conditions, according to a recent study published in the Journal of Clinical Investigation.
-
Checkpoint Inhibitor Plus Chemotherapy Improves Outcomes for Hodgkin Lymphoma
Adding a checkpoint inhibitor to conventional chemotherapy improved outcomes for patients with relapsed or refractory classic Hodgkin lymphoma, according to a Northwestern Medicine phase II clinical trial published in JAMA Oncology.
-
CHET Juneteenth Celebration Addresses Health Disparities Experienced by the Black Community
The Center for Health Equity Transformation (CHET) held its annual Juneteenth Celebration of Black Culture, Art and Music webinar on June 15, and featured a discussion exploring persistent health disparities experienced by the Black community.
-
ISGMH Hosts State of Sexual and Gender Minority Health Symposium in DC
The Institute for Sexual and Gender Minority Health and Wellbeing convened scientists, policymakers, community organizations and LGBTQ+ community members to discuss the inclusion and advancement of LGBTQ+ individuals in STEM fields for its annual State of Sexual and Gender Minority Health Symposium, held in Washington, D.C..
